Poland· PL-100095486
Temodal
A temozolomide product containing temozolomidum, registered in Poland by Merck Sharp & Dohme B.V.. The same ATC class is registered in 17 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Temozolomide is registered in 17 of 19 countries.
Countries holding a registration under ATC L01AX03 (temozolomide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Temozolomide · ATC L01AX03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of temozolomide costs, country by country.
Normalised to the WHO defined daily dose (65 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Temozolomide · price per daily dose (65 mg)
USD · FX 28 Sept 2026
- IT Italy$43.87
- CH Switzerland$34.49
The record
At a glance
URPL (Poland)- Active substance
- Temozolomidum
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Poland (PL)
- ATC code
- L01AX03
- ATC class
- Temozolomide
- Defined daily dose
- 65 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990814015
- gtin05909990814022
- gtin05909990672189
- gtin05909990672172
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
354 interactions on record for temozolomide.
Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Temozolomide · interactions on record
354 records
- 33 severe
- 103 moderate
- 16 minor
- 202 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- CladribineL01BB04severe
- PexidartinibL01EX15severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Temozolomide in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainTEMODAL 100 MG CAPSULAS DURASMerck Sharp & Dohme B.V.
- CzechiaTEMODALMerck Sharp & Dohme B.V., Haarlem
- United StatesTEMODARMerck Sharp & Dohme LLC
- United KingdomTemodal 100mg capsulesMerck Sharp & Dohme (UK) Ltd
- NetherlandsBlastomat 100 mg, harde capsulesZentiva k.s.
- FinlandTemodalMerck Sharp & Dohme B.V.
- SwedenTemodal 100 mg Kapsel, hårdMerck Sharp & Dohme BV
- BelgiumTemodal 100 mgMerck Sharp & Dohme
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Cyprus · Advecit, Ridoca
- Czechia · Temozolomide Glenmark
- Germany · Temozo-Cell, Temozolomid Cipla
- Denmark · Temozolomid Fair-Med, Temozolomid Stada
- Estonia · Blastomat
- Finland · Temozolomid Ratiopharm
- France · Kimozo, Temozolomide Viatris
- United Kingdom (Northern Ireland) · Temozolomide, Temozolomide Crescent Pharma
- Greece · Ridoca
- Croatia · Temazol, Temozolomid Pgf Pharma
- Hungary · Temozolomide Pharmacenter
- Ireland · Temozolomide Clonmel, Temozolomide Fair-Med
- Iceland · Temodal, Temomedac
- Liechtenstein · Temodal, Temomedac
- Lithuania · Blastomat
- Latvia · Blastomat
- Malta · Temozolomide Clonmel 100mg Hard Capsules, Temozolomide Clonmel 140mg Hard Capsules
- Netherlands · Blastomat, Nogron
- Norway · Temodal, Temomedac
- Portugal · Temozolomida, Temozolomide
- Romania · Temozolomidă Hf
- Sweden · Temozolomid Stada, Temozolomide Pgf Pharma
- Slovakia · Temostad
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/969a9d1a-efbd-416e-bc52-ef89a4fa1762 GET /v1/drugs/969a9d1a-efbd-416e-bc52-ef89a4fa1762?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "100 mg",
"packaging": "05909990814015 ¦ Rpz ¦ EU/1/98/096/005 ¦ 15897\n1 butelka 5 kaps.\n05909990814022 ¦ Rpz ¦ EU/1/98/096/006 ¦ 15898\n1 butelka 20 kaps.\n05909990672172 ¦ Rpz ¦ EU/1/98/096/015 ¦ 46878\n5 kaps. w saszetce\n05909990672189 ¦ Rpz ¦ EU/1/98/096/016 ¦ 46879\n20 kaps. w saszetce",
"substance": "Temozolomidum 100 mg",
"common_name": "Temozolomidum",
"pl_product_id": "100095486",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about temozolomide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.